IP Library Granted Patent US 8,558,004
Granted Patent B2
US 8,558,004 · App. 13/019,737 · Granted Oct 15, 2013

Reagents and kits for detection of influenza virus and the like

Inventors: Xing-Xiang Li (Vienna, VA); Tianxin Wang (Boyds, MD)
Assignee: Cellex, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,558,004
App. No.
13/019,737
Granted
Oct 15, 2013
Kind
B2
Abstract

The present invention relates to reagents and methods for influenza virus detection. These reagents and methods disclosed in the present invention enable simple, rapid, specific and sensitive detection of influenza virus types A and B. These reagents are N-acetylneuraminic acid-firefly luciferin conjugates which can be cleaved by influenza virus neuraminidase.

Claims (12)

1. A compound of Formula II or a salt thereof

2. A method for detecting β-galactosaminidase in a sample, comprising:(a) contacting said sample with a compound of Formula II according to claim 1 under conditions effective for the compound to be cleaved by β-galactosaminidase to release firefly luciferin; and (b) detecting the released firefly luciferin.

3. The method according to claim 2 , wherein said released firefly luciferin is detected via a biochemiluminescence reaction in the presence of firefly luciferase.

4. The method according to claim 2 , wherein said β-galactosaminidase is yeast β-galactosaminidase.

5. A method for detecting Candida yeast in a sample, comprising:(a) contacting said sample with a compound of claim 1 under conditions effective for the compound to be cleaved by Candida yeast β-galactosaminidase to release firefly luciferin; and (b) detecting the released firefly luciferin.

6. The method according to claim 5 , wherein said released firefly luciferin is detected via a biochemiluminescence reaction in the presence of firefly luciferase.

7. The method according to claim 5 , wherein said β-galactosaminidase is Candida albican β-galactosaminidase.

8. A method for diagnosing yeast vaginosis in a subject in need thereof comprising

(a) contacting a biological sample from said subject with a compound of Formula II according to claim 1 under conditions effective for the compound to be cleaved by yeast β-galactosaminidase to release firefly luciferin; and

(b) detecting the released firefly luciferin.

9. The method according to claim 8 , wherein said yeast is member of Candida sp.

10. The method according to claim 8 , wherein said subject is a human patient or a veterinary animal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2020
From: CELLEX (SHENZHEN)
To: CELLEX, INC.
Reel/Frame 054663/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2019
From: CELLEX, INC.
To: CELLEX (SHENZHEN)
Reel/Frame 048305/0209 →
Continuity (4)
Continuation 12121213 · May 15, 2008
Provisional Application 60930207 · May 15, 2007
Provisional Application 60999166 · Oct 16, 2007
Related Publication 20110189655A1 · Aug 4, 2011